96 related articles for article (PubMed ID: 1936070)
1. The metabolic fate of the anti-parkinsonian drug budipine in rats.
Caputo O; Grosa G; Ceruti M; Rocco F; Biglino G
Eur J Drug Metab Pharmacokinet; 1991; 16(2):113-8. PubMed ID: 1936070
[TBL] [Abstract][Full Text] [Related]
2. Budipine and the MPTP binding site.
Przuntek H; Russ H
Lancet; 1985 Jul; 2(8445):35-6. PubMed ID: 2861470
[No Abstract] [Full Text] [Related]
3. The metabolic fate of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration. II. Isolation and identification of metabolites.
Gerding TK; Drenth BF; de Zeeuw RA; Tepper PG; Horn AS
Xenobiotica; 1990 May; 20(5):525-36. PubMed ID: 1971984
[TBL] [Abstract][Full Text] [Related]
4. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
Prakash C; Cui D; Potchoiba MJ; Butler T
Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
[TBL] [Abstract][Full Text] [Related]
5. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
Biggs CS; Starr MS
Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
[TBL] [Abstract][Full Text] [Related]
6. Excretion and biotransformation of cisapride in rats after oral administration.
Meuldermans W; Hendrickx J; Lauwers W; Hurkmans R; Mostmans E; Swysen E; Bracke J; Knaeps A; Heykants J
Drug Metab Dispos; 1988; 16(3):410-9. PubMed ID: 2900733
[TBL] [Abstract][Full Text] [Related]
7. The antiparkinsonian drug budipine binds to NMDA and sigma receptors in postmortem human brain tissue.
Kornhuber J; Herr B; Thome J; Riederer P
J Neural Transm Suppl; 1995; 46():131-7. PubMed ID: 8821048
[TBL] [Abstract][Full Text] [Related]
8. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
Biggs CS; Fisher A; Starr MS
Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
[TBL] [Abstract][Full Text] [Related]
9. [Study on hydroxylated metabolites of benproperine in human urine].
Du ZM; Huang HH; Chen XY; Zhong DF
Yao Xue Xue Bao; 2000 Dec; 35(12):916-20. PubMed ID: 12567915
[TBL] [Abstract][Full Text] [Related]
10. Excretion and metabolism of lorcainide in rats, dogs and man.
Meuldermans W; Hurkmans R; Swysen E; Hendrickx J; Thijssen J; Lauwers W; Heykants J
Eur J Drug Metab Pharmacokinet; 1983; 8(4):335-49. PubMed ID: 6673971
[TBL] [Abstract][Full Text] [Related]
11. Oxidative metabolism of butylated hydroxytoluene by hepatic and pulmonary microsomes from rats and mice.
Thompson JA; Malkinson AM; Wand MD; Mastovich SL; Mead EW; Schullek KM; Laudenschlager WG
Drug Metab Dispos; 1987; 15(6):833-40. PubMed ID: 2893710
[TBL] [Abstract][Full Text] [Related]
12. [Metabolism of antiparkinson drugs. An example of competitive hydroxylation].
Stock B; Spiteller G
Arzneimittelforschung; 1979; 29(4):610-5. PubMed ID: 582755
[TBL] [Abstract][Full Text] [Related]
13. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of a new thiazolidinedione hypoglycemic agent CP-68,722 in rat: metabolite identification by gas chromatography mass spectrometry.
Fouda HG; Lukaszewicz J; Clark DA; Hulin B
Xenobiotica; 1991 Jul; 21(7):925-34. PubMed ID: 1776268
[TBL] [Abstract][Full Text] [Related]
15. The effect of budipine on the central serotoninergic system.
Przegaliński E; Bigajska K; Lewandowska A
Pol J Pharmacol Pharm; 1982; 34(5-6):309-15. PubMed ID: 7187046
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 3-tert-butyl-4-hydroxyanisole to 3-tert-butyl-4,5-dihydroxyanisole by rat liver microsomes.
Armstrong KE; Wattenberg LW
Cancer Res; 1985 Apr; 45(4):1507-10. PubMed ID: 3978617
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of selegiline in humans. Identification, excretion, and stereochemistry of urine metabolites.
Shin HS
Drug Metab Dispos; 1997 Jun; 25(6):657-62. PubMed ID: 9193866
[TBL] [Abstract][Full Text] [Related]
18. Directly coupled liquid chromatography with inductively coupled plasma mass spectrometry and orthogonal acceleration time-of-flight mass spectrometry for the identification of drug metabolites in urine: application to diclofenac using chlorine and sulfur detection.
Corcoran O; Nicholson JK; Lenz EM; Abou-Shakra F; Castro-Perez J; Sage AB; Wilson ID
Rapid Commun Mass Spectrom; 2000; 14(24):2377-84. PubMed ID: 11114054
[TBL] [Abstract][Full Text] [Related]
19. Dose linearity and steady state pharmacokinetics of the new antiparkinson agent budipine after oral administration.
Bethke TH; Merz M; Zech K; Seiberling M; Hauschke D; Heinze H; Wurst W
Int J Clin Pharmacol Ther; 2001 Jun; 39(6):259-64. PubMed ID: 11430634
[TBL] [Abstract][Full Text] [Related]
20. Identification of a biliary metabolite of cisapride.
Lauwers W; Le Jeune L; Meuldermans W
Biomed Environ Mass Spectrom; 1988 Mar; 15(6):323-8. PubMed ID: 3378119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
